ClinicalTrials.gg
CompletedNCT05873582RAS-AheadUpdated Nov 17, 2026

Robotic Minimally Invasive Inguinal Hernia Repair With Dexter

An observational study in Inguinal Hernia Repair, sponsored by Distalmotion SA. Completed at 3 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Distalmotion SA · Observational

How we know

Updated Nov 17, 2026Results publication addedSponsor changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing primary transperitoneal unilateral or bilateral inguinal hernia repair.

02

Conditions studied

  • Inguinal Hernia Repair

Browse trials for

03

In context

Hernia, Inguinal

545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.

This study's enrollment of 50 is below the median of 134 across 137 observational studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Distalmotion SA is the lead sponsor of 9 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

adult patients undergoing primary transperitoneal unilateral or bilateral inguinal hernia repair

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged > 18 years
  • Patients planned to undergo elective robot-assisted and laparoscopic surgery for primary unilateral or bilateral inguinal hernia repair using one camera port, two ports for the manipulating instruments, and additional ports as needed.
  • Able to provide according to local regulation

Exclusion criteria

Exclusion Criteria:

  • Morbidly obese patients ( > 40)
  • Any relative and absolute for the use of conventional endoscopes and endoscopic surgical instruments
  • Need for robotic stapling, advanced energy delivery, ultrasound, cryoablation and microwave energy delivery
  • Bleeding diathesis
  • Pregnancy
  • Patients with pacemakers or internal defibrillators
  • Any planned concomitant procedures
  • Patient deprived of liberty by administrative or judicial decision or under legal guardianship
  • Participation in another interventional clinical trial
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
50 participants (actual)
Patient registry
No

Interventions

  • DeviceRobotic-assisted inguinal hernia repair

    Primary transperitoneal unilateral or bilateral inguinal hernia repair with the Dexter robotic system

06

What researchers measure

Primary outcomes

  1. Safety: occurrence of serious (Clavien - Dindo grades III-V), device-related, adverse events

    Time frame: perioperatively up to 30 days

  2. Performance: successful completion of the Dexter-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach

    Time frame: intraoperative

07

Study locations

3 sites
  • Centre Hospitalier de Saintes
    Saintes, France
  • UKSH Kiel
    Kiel, 24105, Germany
  • Kantonspital Winterthur
    Winterthur, Switzerland
08

References and documents

Publications

  • Gantner L, Mignot H, Pochhammer J, Grieder F, Breitenstein S. Robotic minimally invasive inguinal hernia repair with the Dexter robotic system: A prospective multicenter clinical investigation. Surg Endosc. 2024 Dec;38(12):7647-7655. doi: 10.1007/s00464-024-11361-1. Epub 2024 Nov 14. PubMed 39542890 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2023 to primary completion in Oct 2023, 4 months.

Of 57 observational studies under Hernia, Inguinal, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 68. This study's 4 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
May 15, 2023
First posted
May 24, 2023
StartActual
Jun 2, 2023
Primary completionActual
Oct 23, 2023
CompletionActual
Oct 23, 2023
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Publications
Results publication added: Gantner L, Mignot H, Pochhammer J, Grieder F, Breitenstein S. Robotic minimally invasive inguinal hernia repair with the Dexter robotic system: A prospective m… PubMed 39542890 ↗
Nov 17, 2026
Sponsor
Collaborators added: Confinis; collaborators removed: confinis AG
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Publications Results publication added: Gantner L, Mignot H, Pochhammer J, Grieder F, Breitenstein S. Robotic minimally invasive inguinal hernia repair with the Dexter robotic system: A prospective m… PubMed 39542890 ↗
    Sponsor Collaborators added: Confinis; collaborators removed: confinis AG
    + 2 other changes: verification date and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05873582
Lead sponsor
Distalmotion SA
Collaborators
Confinis
Responsible party
Sponsor
First posted
May 24, 2023
Start date
Jun 2, 2023
Primary completion
Oct 23, 2023
Completion
Oct 23, 2023
Last update
Nov 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion